Peaper David R, Durant Thomas, Campbell Sheldon
Department of Laboratory Medicine, Yale School of Medicine, Pathology and Laboratory Medicine, VA Connecticut Health Care, New Haven, CT 06504, USA.
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06504, USA.
Clin Lab Med. 2019 Sep;39(3):419-431. doi: 10.1016/j.cll.2019.05.004.
We discuss the current practice of point-of-care diagnostics in infectious diseases as methods transition from antigen-based to molecular, and beyond simple molecular to the next generations of point-of-care testing methods. We evaluate the role of point-of-care at different sites of care and describe and evaluate trends likely to be driven by advances in molecular methodology, emerging biomarkers, and informatics. We describe strengths, weaknesses, opportunities, and threats to the development of point-of-care diagnostics in the near (1-10 years) and more distant (10-20 years) future.
随着传染病即时诊断方法从基于抗原的方法过渡到分子方法,以及从简单的分子方法发展到下一代即时检测方法,我们讨论了当前传染病即时诊断的实践情况。我们评估了即时诊断在不同护理场所的作用,并描述和评估了可能由分子方法学进展、新兴生物标志物和信息学推动的趋势。我们描述了在近期(1至10年)和更长远期(10至20年)即时诊断发展的优势、劣势、机遇和挑战。